China Supplied Faulty Coronavirus Test Kits to Spain, Czech

New Post Public Reply Private Reply Replies (1) Message Board
Wheelhorse
580
China Supplied Faulty Coronavirus Test Kits to Spain, Czech Republic
Mairead McArdle
National ReviewMarch 26, 2020, 11:23 AM CDT

The majority of rapid test coronavirus test kits supplied by China to Spain and the Czech Republic are faulty, local news outlets reported.

Up to 80 percent of the 150,000 portable, quick coronavirus test kits China delivered to the Czech Republic earlier this month were faulty, according to local Czech news site Expats.cz. The tests can produce a result in 10 or 15 minutes but are usually less accurate than other tests. Because of the high error rate, the country will continue to rely on conventional laboratory tests, of which they perform about 900 a day.

The country’s Health Ministry paid $546,000 for 100,000 of the test kits, while the Interior Ministry paid for the other 50,000.

Deputy Prime Minister and Interior Minister Jan Hamacek downplayed the discovery that many of the tests were faulty, blaming it on a possible wrong methodology and saying the kits can still be used “when the disease has been around for some time,” or when “someone returns after quarantine after fourteen days.”

“In my opinion, this is not about some scandalous revelation that it is not working,” Hamacek said.

Meanwhile, Spain, which has more than 56,000 infected people and more than 4,000 coronavirus deaths, the second-highest number of fatalities in the world after Italy, found that the rapid coronavirus test kits it purchased from Chinese company Bioeasy only correctly identified 30 percent of virus cases, according to Spanish newspaper El Pais.

The director Spain’s Center for Health Alerts and Emergencies, Fernando Simón, said Spain tested 9,000 of the test kits and will return them based on their high error rate.

Studies performed on the tests which discovered the high error rate caused the Spanish Society of Infectious Diseases and Clinical Microbiology to recommend officially that the tests not be used.

The Chinese embassy in Spain claimed the Bioeasy products are not included in the products China has been supplying to countries where the virus has broken ou

Decision Diagnostics Corp (DECN) Stock Research Links

DECN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading